ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
SO WHAT: If you purchased Capricor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Capricor class action, go to https://rosenlegal.com/submit-form/?case_id=42281 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants provided investors with material information concerning deramiocel, Capricor's lead cell therapy candidate drug for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD). Defendants' statements included, among other things, Capricor's ability to obtain a Biologics License Application (BLA) for deramiocel from the U.S. Food and Drug Administration (FDA). Further, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning its four-year safety and efficacy data from its Phase 2 HOPE-2 trial study of deramiocel. The lawsuit alleges this caused shareholders to purchase Capricor's securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Capricor class action, go to https://rosenlegal.com/submit-form/?case_id=42281 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262725
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Earnings Beat and Acquisitions Strengthen Rocket Companies Progress
Rocket Companies, Inc. (NYSE:RKT) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company surpassed Q2 expectations and has bolstered expectations for its Redfin acquisition and pending COOP transaction. A businessperson using a laptop to review the details of a mortgage loan for a client. Rocket Companies, Inc. (NYSE:RKT) is a leading fintech platform delivering mortgage lending, real estate brokerage, personal finance, and homeownership solutions. The Michigan-based company's ecosystem includes Rocket Mortgage, Rocket Homes, Rocket Close, and Rocket Money. Its business model involves leveraging AI to streamline the homebuying and financial management experience. On July 31, 2025, the company reported achieving an EPS of $0.04 that surpassed the analysts' expectations of $0.03 in its Q2 earnings results. Additionally, Rocket Companies, Inc. (NYSE:RKT)'s revenue reached $1.36 billion, exceeding the projected $1.28 billion, further garnering positive attention from investors. In addition to this, Rocket Companies, Inc. (NYSE:RKT) is anticipated to close the COOP transaction in the fourth quarter of 2025, thus eliminating elevated transaction-related expenses that negatively impacted the company's second-half 2025 earnings. Also, the acquisition of Redfin, completed on July 1, 2025, brought a positive outlook to the company as the combination of the most-visited real estate brokerage website and the U.S.'s largest mortgage lender is expected to improve efficacy. With a short float of 58.38%, Rocket Companies, Inc. (NYSE:RKT) potentially has extreme short interest. However, the stock attracts investor interest as it is subject to a dramatic squeeze in positive momentum. While we acknowledge the potential of RKT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best REIT Stocks to Buy Right Now and 10 Stocks with Huge Catalysts on the Horizon Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Giants' Justin Verlander's brother downplays Dodgers superstar Shohei Ohtani's $240M distraction
Giants' Justin Verlander's brother downplays Dodgers superstar Shohei Ohtani's $240M distraction originally appeared on The Sporting News The Los Angeles Dodgers haven't been playing particularly well lately, including suffering a mid-week sweep at the hands of the Angels. In fact, the Dodgers lost every game they played against the Angels this season. During the series, former Angel Shohei Ohtani found himself on the wrong side of history. 'According to Baseball Almanac's tracker of every triple play in MLB history, it marked just the eighth the Angels have ever turned. As for the Dodgers, they have now fallen victim to 24 triple plays. There had never been a triple play in the 152 games between the Dodgers and Angels since the Freeway Series began in 1997,' SI's Sam Connon wrote. Off the field, Ohtani is facing growing distractions, including an ongoing lawsuit. 'A Hawaii real estate investor and broker are suing Shohei Ohtani, claiming the Los Angeles Dodgers star and his agent got them fired from a $240 million luxury housing development on the Big Island's coveted Hapuna Coast that they brought him in to endorse,' The Associated Press's Jimmy Golen wrote. 'According to the lawsuit filed in Hawaii Circuit Court on Friday, Ohtani's agent, Nez Balelo, increasingly demanded concessions from developer Kevin J. Hayes Sr. and real estate broker Tomoko Matsumoto before demanding that their business partner, Kingsbarn Realty Capital, drop them from the deal.' While the situation is unfolding off the field, MLB analyst and Justin Verlander's brother, Ben Verlander, has attempted to downplay its significance. 'In a since-deleted tweet, Verlander dismissed the $240 million legal fight by telling fans, 'Let's all remember to not just get mad because you see his name attached to something. If his name wasn't Shohei Ohtani we wouldn't even know about this,'' Alvin Garcia wrote. 'He added, 'Never seen so many people care about CIVIL lawsuits regarding real estate.'' Follow The Sporting News on WhatsApp Verlander has certainly minimized the seriousness of the ongoing situation, which could escalate quickly. The Dodgers have done well to keep the matter from becoming a clubhouse distraction. However, Verlander's public comments aren't a good look. Ohtani will continue to play, but if the lawsuit doesn't go well, Verlander's dismissive remarks may come back to haunt him for a long time.
Yahoo
40 minutes ago
- Yahoo
The US plans to build a $750M fly factory in Texas to stop a flesh-eating cattle parasite
The U.S. plans to build a $750 million factory in southern Texas to breed billions of sterile flies, ramping up its efforts to keep flesh-eating maggots in Mexico from crossing the border and damaging the American cattle industry. Secretary Brooke Rollins announced Friday that the U.S. Department of Agriculture hopes to be producing and releasing sterile male New World screwworm flies into the wild within a year from the new factory on Moore Air Base outside Edinburg, Texas, about 20 miles (32 kilometers) from the border. She also said the USDA plans to deploy $100 million in technology, such as fly traps and lures, and step up border patrols by 'tick riders' mounted on horseback and train dogs to sniff out the parasite. In addition, Rollins said the U.S. border will remain closed to cattle, horse and bison imports from Mexico until the U.S. sees that the pest is being pushed back south toward Panama, where the fly had been contained through late last year through the breeding of sterile flies there. The U.S. has closed its border to those imports three times in the past eight months, the last in July, following a report of an infestation about 370 miles (595 kilometers) from the Texas border. American officials worry that if the fly reaches Texas, its flesh-eating maggots could cause billions of dollars in economic losses and cause already record retail beef prices to rise even more, fueling greater inflation. The parasite also can infest wildlife, household pets and, occasionally, humans. 'Farm security is national security,' Rollins said during a news conference at the Texas State Capitol in Austin with Texas Gov. Greg Abbott. 'All Americans should be concerned. But it's certainly Texas and our border and livestock producing states that are on the front lines of this every day.' The pest was a problem for the American cattle industry for decades until the U.S. largely eradicated it in the 1970s by breeding and releasing sterile male flies to breed with wild females. It shut down fly factories on U.S. soil afterward. The Mexican cattle industry has been hit hard by infestations and the U.S. closing its border to imports. Mexico's Agriculture ministry said in a statement Friday that Mexico Agriculture and Rural Development Secretary Julio Berdegué Sacristán and Rollins signed a screwworm control action plan. It includes monitoring with fly-attracting traps and establishing that livestock can only be moved within Mexico through government-certified corrals, the statement said. And on the X social media platform, Berdegué said, 'We will continue with conversations that lead to actions that will permit the reopening of livestock exports." The new fly-breeding factory in Texas would be the first on U.S. soil in decades and represents a ramping up of the USDA's spending on breeding and releasing sterile New World screwworm flies. The sterile males are released in large enough numbers that wild females can't help but mate with them, producing sterile eggs that don't hatch. Eventually, the wild fly population shrinks away because females mate only once in their weekslong lives. In June, Rollins announced a plan to convert an existing factory for breeding fruit flies into one for breeding sterile New World Screwworm flies, as well as a plan to build a site, also on the air base near Edinburg, for gathering flies imported from Panama and releasing them from small aircraft. Those projects are expected to cost a total of $29.5 million. The Panama fly factory can breed up to 117 million flies a week, and the new Mexican fly factory is expected to produce up to 100 million more a week. Rollins said the new Texas factory would produce up to 300 million a week. She said President Donald Trump's administration wants to end the U.S. reliance on fly breeding in Mexico and Panama. 'It's a tactical move that ensures we are prepared and not just reactive, which is today what we have really been working through,' Rollins said. ___ Hanna reported from Topeka, Kansas. Associated Press writer Fabiola Sánchez in Mexico City contributed reporting. Solve the daily Crossword
